As global capital recalibrates in response to shifting macroeconomic conditions, private markets are entering a new era of discipline, innovation, and selective opportunity.
This panel explores how leading Family Offices and institutional investors are redefining their strategies across private equity, venture capital, private credit and real assets.
The discussion will uncover where sophisticated capital is being deployed in 2026, from secondaries and co-investments to emerging sectors such as climate tech, AI infrastructure, and next-generation healthcare. Panelists will share insights on navigating liquidity constraints, optimizing portfolio construction, and identifying resilient, high-growth opportunities in an increasingly competitive landscape.
Designed for forward-thinking investors, this session provides a strategic lens into how “smart money” is positioning itself to capture alpha in private markets, balancing risk, access and long-term value creation in a rapidly evolving investment environment.

As wealth transitions across generations, Family Offices are increasingly aligning capital with purpose, seeking not only financial returns, but measurable social and environmental impact. This panel explores how legacy capital is being strategically deployed to address global challenges while preserving and enhancing long-term value.

Bringing together leading investors and thought leaders, the discussion will examine the evolution of impact investing, from philanthropy-driven initiatives to institutional-grade strategies across sectors such as climate, agriculture and sustainable infrastructure. Panelists will share how they define impact, measure performance and integrate ESG considerations into their investment frameworks without compromising returns.

With a focus on stewardship, governance, and intergenerational vision, this session offers a refined perspective on how Family Offices are shaping a legacy that extends beyond wealth—driving meaningful change while securing enduring prosperity.

Saudi family offices are seizing opportunities to invest in transformative technologies that shape the future of global industries.

The convergence of technology and healthcare is redefining the future of human longevity, prevention, and personalized medicine. From AI-driven diagnostics and digital health platforms to breakthroughs in biotech and genomics, a new wave of innovation is transforming how care is delivered, accessed, and financed.

This panel brings together visionary investors, founders and healthcare leaders to explore where capital is flowing within healthtech and life sciences and why. Discussions will highlight emerging opportunities across precision medicine, longevity science, mental health technologies and decentralized care models, as well as the regulatory, ethical, and scalability challenges that accompany rapid innovation.

Designed for forward-looking Family Offices and institutional investors, this session offers strategic insights into identifying high-impact opportunities at the intersection of technology and human health, where financial returns align with advancing the quality and lifespan of human life.